Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
CNY 63.1
(1.25%)
CNY 63.1
(1.25%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 393.22 Thousand CNY | 30.81% |
| 2022 | 300.59 Thousand CNY | -55.71% |
| 2021 | 678.75 Thousand CNY | -82.59% |
| 2020 | 3.89 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - CNY | 0.0% |
| 2024 Q2 | 265.54 Thousand CNY | 0.0% |
| 2024 Q1 | 233.89 Thousand CNY | 0.0% |
| 2023 Q4 | 393.22 Thousand CNY | -75.19% |
| 2023 FY | 393.22 Thousand CNY | 30.81% |
| 2023 Q3 | 1.58 Million CNY | -25.96% |
| 2023 Q1 | 2.48 Million CNY | 726.15% |
| 2023 Q2 | 2.14 Million CNY | -13.79% |
| 2022 Q2 | 140.75 Thousand CNY | -36.45% |
| 2022 Q1 | 221.48 Thousand CNY | -67.37% |
| 2022 Q4 | 300.59 Thousand CNY | -38.23% |
| 2022 FY | 300.59 Thousand CNY | -55.71% |
| 2022 Q3 | 486.65 Thousand CNY | 245.75% |
| 2021 Q2 | 8.88 Million CNY | -18.96% |
| 2021 Q3 | 6.47 Million CNY | -27.14% |
| 2021 FY | 678.75 Thousand CNY | -82.59% |
| 2021 Q1 | 10.95 Million CNY | 181.09% |
| 2021 Q4 | 678.75 Thousand CNY | -89.51% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 3.89 Million CNY | 0.0% |
| 2020 Q4 | 3.89 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |